Synergy has a mechanism or it isn't real
The classic example is CJC-1295 with Ipamorelin. One acts on the GHRH receptor and the other on the ghrelin receptor, and because they push the same pituitary output through two different doors, the combined GH pulse is larger than either alone. That is genuine synergy.
Stacking two compounds that hit the same receptor, by contrast, buys you side effects rather than results. If you cannot name the two distinct pathways a stack uses, it is probably just an expensive single protocol.
Common stacks and their logic
- CJC-1295 + Ipamorelin — dual-pathway GH release, standard evening protocol
- BPC-157 + TB-500 — local repair signalling plus systemic cell migration
- Semax + Selank — stimulating focus balanced against anxiolytic calm
- GLP-1 agonist + resistance training and high protein — the non-negotiable pairing to limit muscle loss
Why cycling matters
Receptors downregulate under constant stimulation. Ghrelin-receptor agonists in particular lose potency with continuous use, which is why most GH protocols run 8–12 weeks followed by roughly four weeks off.
Cycling also creates a natural review point: bloodwork, an honest assessment of whether anything improved, and a decision about whether to continue at all. Continuous year-round use of unapproved compounds has no safety data behind it.
Introduce one variable at a time
Start a single compound at the low end of its range for at least two weeks before adding anything else. If you begin three peptides on the same day and develop a headache, you have learned nothing about which one caused it.
Track sleep, training performance, weight and any side effects in writing. Subjective memory is unreliable, and most peptide effects are subtle enough to be confused with placebo without a record.